The MasLD circuit

multidisciplinary and personalized support

Liver assessment

  • Assessment of fibrosis by non-invasive methods, serum markers, fibroscan, aixplorer
  • Assessment of cirrhosis, portal hypertension / liver cancer screening

Cardiovascular risk

  • Early atherosclerosis: coronary CT scan with calcium score measurement

Metabolic assessment

  • Diabetes screening
  • Body composition assessment by DXA


Global risk stratification

HEPATIC

Progression of fibrosis / cirrhosis / decompensation cirrhosis / cancer / liver-related death

CARDIAC

Cardiovascular event

Death

BIOLOGICAL ASSESSMENT

Individualized support

Bariatric surgery

Endoscopy, intragastric balloon

Primary/secondary cardiovascular prevention (risk factors, statins)

Cardiology

Therapeutic protocols

Dietetic consultation

Adapted physical activity

Therapeutic education